As a variety of novel cell- or gene-based therapies move closer to the clinic, or to market approval in a few cases, Bethan Hughes explores the rapidly evolving regulatory environment for such products.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Laying the regulatory path for advanced therapies. Nat Rev Drug Discov 7, 464–465 (2008). https://doi.org/10.1038/nrd2610
Issue Date:
DOI: https://doi.org/10.1038/nrd2610
- Springer Nature Limited
This article is cited by
-
News in brief
Nature Reviews Drug Discovery (2009)